Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd. clinical trials

A subsidiary of Fosun Pharma

The registry lists 2 studies whose lead sponsor is Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Status

Not yet recruiting: 2

Phase

Phase 1: 1
Phase 2: 1

Where

China: 2

Registry sponsor names on this page

Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.2 studies

Something wrong with this grouping? Tell us on the Fosun Pharma page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Fosun Pharma studies →

A Phase II Study of FXR0906 in Patients With Severe Hypertriglyceridemia or Hypertriglyceridemia With ASCVD.Not yet recruitingNCT07889245Phase 2
Sponsor listed in the registry: Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated TriglyceridesNot yet recruitingNCT07766759Phase 1
Sponsor listed in the registry: Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.